XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development, net of grant reimbursement $ 14,906 $ 2,529
General and administrative 2,915 1,004
Total operating expenses 17,821 3,533
Operating loss (17,821) (3,533)
Interest income 31 7
Other income, net 263  
Net loss $ (17,527) $ (3,526)
Net Loss Per Share Basic And Diluted $ (0.44) $ (0.09)
Shares used in computing net loss per share, basic and diluted 39,962 37,721